Novel biomarker derived from EBV promising for mass screening for nasopharyngeal cancer: NEJM
China: A recent study has shown anti–BNLF2b total antibody (P85-Ab) to be a promising novel biomarker for screening of nasopharyngeal carcinoma, with higher specificity, sensitivity, and positive...
Source: medicaldialogues.in